Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
17
pubmed:dateCreated
2001-8-30
pubmed:abstractText
A series of glycolic and mandelic acid derivatives was synthesized and investigated for their factor Xa inhibitory activity. These analogues are highly potent and selective inhibitors against fXa. In a rabbit deep vein thrombosis model, compound 26 showed significant antithrombotic effects (81% inhibition of thrombus formation) at 1.1 microM plasma concentration following intravenous administration.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0960-894X
pubmed:author
pubmed:issnType
Print
pubmed:day
3
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2279-82
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:11527714-Acetanilides, pubmed-meshheading:11527714-Amidines, pubmed-meshheading:11527714-Animals, pubmed-meshheading:11527714-Biological Availability, pubmed-meshheading:11527714-Blood Coagulation Tests, pubmed-meshheading:11527714-Drug Design, pubmed-meshheading:11527714-Drug Evaluation, Preclinical, pubmed-meshheading:11527714-Factor Xa, pubmed-meshheading:11527714-Fibrinolysin, pubmed-meshheading:11527714-Inhibitory Concentration 50, pubmed-meshheading:11527714-Injections, Intravenous, pubmed-meshheading:11527714-Mandelic Acids, pubmed-meshheading:11527714-Phenylacetates, pubmed-meshheading:11527714-Rabbits, pubmed-meshheading:11527714-Rats, pubmed-meshheading:11527714-Rats, Sprague-Dawley, pubmed-meshheading:11527714-Serine Proteinase Inhibitors, pubmed-meshheading:11527714-Structure-Activity Relationship, pubmed-meshheading:11527714-Venous Thrombosis
pubmed:year
2001
pubmed:articleTitle
Design and synthesis of glycolic and mandelic acid derivatives as factor Xa inhibitors.
pubmed:affiliation
COR Therapeutics, Inc., 256 East Grand Avenue, South San Francisco, CA 94080, USA. tsu@corr.com
pubmed:publicationType
Journal Article